The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PSMA PET findings in patients with undetectable PSA more than 3 years after docetaxel for metastatic castration-sensitive prostate cancer (mCSPC).
 
Mohammad O. Atiq
Travel, Accommodations, Expenses - Agios; Alnylam (I); Astellas Pharma; AstraZeneca (I); Celgene; Daiichi Sankyo Inc. (I); Foundation Medicine (I); Genentech (I); Gilead Sciences (I); Incyte; Jazz Pharmaceuticals; Pfizer; Pfizer (I); Rigel; Rigel
 
Shruti U. Gandhy
No Relationships to Disclose
 
Fatima Karzai
No Relationships to Disclose
 
Munjid Al Harthy
No Relationships to Disclose
 
Gang Chen
No Relationships to Disclose
 
Marijo Bilusic
Research Funding - Bavarian Nordic (Inst); ImmunityBio (Inst); NextCure (Inst)
 
David James VanderWeele
Consulting or Advisory Role - Clovis Oncology; Exelixis; Janssen
Research Funding - AstraZeneca (Inst); Department of Defense-Prostate Cancer Research Program; Fortis (Inst); Prostate Cancer Foundation
 
Elias Bin Aris Chandran
Stock and Other Ownership Interests - Pacific Edge Biotechnology
 
Lisa M. Cordes
No Relationships to Disclose
 
Helen Owens
No Relationships to Disclose
 
Anna Couvillon
No Relationships to Disclose
 
Amy Hankin
Stock and Other Ownership Interests - Amgen; Medtronic
 
Monique Williams
No Relationships to Disclose
 
William Douglas Figg
Research Funding - Astellas Pharma (Inst); Biocompatibles (Inst); Celgene (Inst); Nerviano Medical Sciences (Inst); NovaRX (Inst); Pfizer (Inst); TRACON Pharma (Inst)
 
Peter L. Choyke
Patents, Royalties, Other Intellectual Property - I am a patent holder for MRI-Ultrasound fusion technology licensed to InVivo which markets it as UroNav. However, as a government employee I personally receive no financial benefit from this patent.
Other Relationship - Aspyrian Therapeutics; GE Healthcare; Philips Healthcare
 
Liza Lindenberg
No Relationships to Disclose
 
Esther Mena
No Relationships to Disclose
 
William L. Dahut
Leadership - Dexcom (I)
Stock and Other Ownership Interests - Dexcom (I)
 
James L. Gulley
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); ImmunityBio (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - COMBINATION PDL1 AND TGF-BETA BLOCKADE IN PATIENTS WITH HPV+ MALIGNANCIES Publication number: 20200062849 Abstract: The invention provides a method of inhibiting a malignancy associated with human papilloma virus (HPV) comprising administering to a subje
 
Ravi Amrit Madan
Speakers' Bureau - Boehringer Ingelheim (I); Janssen (I); Pfizer (I)
Research Funding - Bayer